Antisense antibacterial method and compound

Details for Australian Patent Application No. 2005327188 (hide)

Owner AVI BioPharma, Inc.

Inventors Geller, Bruce L.; Iversen, Patrick L.; Deere, Jesse D.

Agent Davies Collison Cave

Pub. Number AU-B-2005327188

PCT Pub. Number WO2006/085973

Priority 60/585,112 02.07.04 US

Filing date 1 July 2005

Wipo publication date 17 August 2006

Acceptance publication date 17 March 2011

International Classifications

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2006/085973 Priority application(s): WO2006/085973

17 March 2011 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 27 Feb 2011. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000 2006

17 March 2011 Application Accepted

  Published as AU-B-2005327188

7 July 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 27 Feb 2011 2006

14 July 2011 Standard Patent Sealed

22 September 2011 Corrigenda

  Amendments - Amendments Made Under the name AVI BioPharma, Inc., Application No. 2005327188, correct the statement filed date to read 28 Feb 2011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005327194-Soluble forms of Hendra and Nipah virus G glycoprotein

2005327186-Detection of analytes